Hepatitis C virus structural proteins induce liver cell injury in transgenic mice

Journal of Medical Virology

Volumn 59, Issue 3, 1999, Pages 281-289

  Honda, Arata ^a   Arai, Yutaka ^a   Hirota, Norio ^b   Sato, Takako ^c   Ikegaki, Junichi ^d   Koizumi, Tamio ^d   Hatano, Masahiko ^a   Kohara, Michinori ^e   Moriyama, Takashi ^b   Imawari, Michio ^b   Shimotohno, Kunitada ^f   Tokuhisa, Takeshi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d Hyogo Institute of Clinical Research   (Japan)

^e TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^f KYOTO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Fas; Hepatitis C virus; Transgenic mice

Indexed keywords

STRUCTURAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; IMMUNOHISTOCHEMISTRY; LIVER CELL DAMAGE; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PROTEIN INDUCTION; TRANSGENIC MOUSE; VIRUS CORE; VIRUS MORPHOLOGY;

ALPHA-FETOPROTEINS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; HEPACIVIRUS; HEPATITIS C; LIVER; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, TRANSGENIC; RNA, VIRAL; VIRAL CORE PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL STRUCTURAL PROTEINS;

ANIMALIA; HEPATITIS C VIRUS; MUS MUSCULUS; RNA VIRUSES;

EID: 0032851094     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199911)59:3<281::AID-JMV4>3.0.CO;2-S     Document Type: Article

References (52)

1. Agnello V, Chung RT, Kaplan LM. 1992. A role for hepatitis C virus infection in type II cryogbbulinemia. N Engl J Med 327:1490-1495.
2. Chen PJ, Wang JT, Hwang LH, Yang YH, Hsieh CL, Kao JH, Sheu JC, Lai MY, Wang TH, Chen DS. 1992. Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in post-transfusion hepatitis C: putative serological marker for acute viral infection. Proc Natl Acad Sci USA 89:5971-5975.
3. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, Brinster RL, Palmiter RD. 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis 8 virus transgenic mice. Cell 59:1145-1156.
4. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
5. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA derived from a blood-borne non-A, non-B hepatitis genome. Science 244:359-362.
6. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby A, Barr PJ, Weiner AJ, Bradley DW, Kuo G, Houghton M. 1991. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451-2455.
7. De Vita S, Sacco C, Sansonno D, Gloghini A, Dammacco F, Crovatto M, Santini G, Dolcetti R, Boiocchi M, Carbone A, Zagonel V. 1997. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 90:776-782.
8. + T lymphocytes in acute and chronic hepatitis C. J Mol Med 74:583-588.
9. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C, Missale G, Marin MG, Fiaccadori F. 1994. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19:286-295.
10. Fukuda T, Yoshida T, Okada S, Hatano M, Miki T, Ishibashi K, Okabe S, Koseki H, Hirosawa S, Taniguchi M, Miyasaka N, Tokuhisa T. 1997. Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med 186:439-448.
11. Gerber MA. 1993. Relation of hepatitis C virus to hepatocellular carcinoma. J Hepatol 17:108-111.
12. Grakoui A, Wychowski S, Lin C, Feinstone S, Rice CM. 1993. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67:1385-1395.
13. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, Mal F, Callard P, Beaugrand M. 1992. Lymphocytic sialoadenitis of Sjøgren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339:321-323.
14. Hijikata M, Kato N, Ooysuyama Y, Nakagawa M, Shimotohno K. 1991. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci USA 88:5547-5551.
15. Hijikata M, Mizushima H, Akagi T, Mori S, Kakiuchi N, Kato N, Shimotohno K. 1993. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol 67:4665-4675.
16. Hirota N, Moriyama S, Yokoyama T. 1982. Induction of γ-glutamyl-transferase-positive and nonspecific esterase-positive foci in rat liver by partial hepatectomy following single injection of N-nitrosodiethylamine. J Natl Cancer Inst 69:1299-1304.
17. Hirota N, Williams GM. 1989. Assessment of hepatocarcinogenesis by early indicators. In: Meeks RD, Harrison SD, Bull RJ, editors. Hepatotoxicology. Boca Raton, FL: CRC Press, p 593-620.
18. Hogan B, Costantini F, Lacy E. 1986. Manipulating the mouse embryo. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
19. Hosein B, Fang CT, Popovski MA, Zhang M, Wang CY. 1991. Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. Proc Natl Acad Sci USA 88: 3647-3651.
20. Houghton M, Weiner A, Han J, Kuo G, Choo QL. 1991. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14:381-388.
21. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG. 1993. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465-470.
22. Kashiwakuma T, Hasegawa A, Kajita T, Takata A, Mori H, Ohta Y, Tanaka E, Kiyosawa K, Tanaka T, Tanaka S, Hattori N, Kohara M., 1996. Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA). J Immunol Methods 190:79-89.
23. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K. 1990. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 87:9524-9528.
24. Kim CM, Koike K, Saito I, Miyamura T, Jay G. 1991. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317-320.
25. Kita H, Moriyama T, Kaneko T, Harase I, Nomura M, Miura H, Nakamura I, Yazaki Y, Imawari M. 1993. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 18:1039-1044.
26. Koike K, Moriya K, Ishibashi K, Matsuura Y, Suzuki T, Saito I, Iino S, Kurokawa K, Miyamura T. 1995. Expression of hepatitis C virus envelope proteins in transgenic mice. J Gen Virol 76:3031-3038.
27. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD. 1992. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 149:3339-3344.
28. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuater JR, Overby LE, Bradley DW, Houghton M. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
29. Lee TH, Finegold MJ, Shen RF, DeMayo JL, Woo SLC, Butel JS. 1990. Hepatitis B virus transactivator × protein is not tumorigenic in transgenic mice. J Virol 64:5939-5947.
30. Leroux-Roels G, Esquivel CA, DeLeys R, Stuyver L, Elewaut A, Philippe J, Desombere I, Paradijs J, Maertens G. 1996. Lymphoproliferative responses to hepatitis C virus core, El, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa. Hepatology 23:8-16.
31. Lippi U, Guidi G. 1970. A new colorimetric ultramicromethod for serum glutamic-oxalacetic and glutamic-pyruvic transaminase determination. Clin Chim Acta 28:431-437.
32. Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Pussini E, Fanni M, Sorio R, Bortolus R, Crovatto M, G Santini G, Tiribelli C, Sasso F, Masutti R, Pozzato G. 1996. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 94:544-550.
33. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K. 1998. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4:1065-1067.
34. Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, Miyamura T, Koike K. 1997. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 78:1527-1531.
35. Muraiso K, Hijikata M, Kato N, Shimotohno K, Okazaki N, Ohkoshi S, Uura M, Kaneko S, Kobayashi K, Omata M, Ohnishi H, Mutou Y, Hattori N. 1991. Detection of hepatitis C virus infection by enzyme-linked immunosorbent assay system using core protein expressed in E. coli. Jpn J Cancer Res 82:879-882.
36. Muraiso K, Hijikata M, Ohkoshi S, Cho M-Y, Kikuchi M, Kato N, Shimotohno K. 1990. A structural protein of hepatitis C virus expressed in E. coli facilitates accurate detection of hepatitis C virus. Biochem Biophys Res Commun 172:511-516.
37. Naito M, Hayashi N, Hagiwara H, Hiramatsu N, Kasahara A, Fusamoto H, Kamada T. 1994. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology 19:871-875.
38. Nishi M, Ishida Y, Honjo T. 1988. Expression of functional interleukin-2 receptors in human light chain/Tac transgenic mice. Nature 331:267-269.
39. Ochi Y, Koizumi T, Kobayashi S, Phuchareon J, Hatano M, Takada M, Tomita Y, Tokuhisa T. 1994. Analysis of IL-2 gene regulation in c-fos transgenic mice. Evidence for an enhancement of IL-2 expression in splenic T cells stimulated via TCR/CD3 complex. J Immunol 153:3485-3490.
40. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S. 1993. Lethal effect of the anti-Fas antibody in mice. Nature 364:806-809.
41. 2-microglobulin genes. Cell 29:661-669.
42. Ravaggi A, Natoli G, Primi D, Albertini A, Levrero M, Cariani E. 1994. Intracellular localization of full-length and truncated hepatitis C virus core protein expressed in mammalian cells. J Hepatol 20:833-836.
43. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, Chisari FV. 1996. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 98:1432-1440.
44. Ruggieri A, Harada T, Matsuura Y, Miyamura T. 1997. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 229:68-76.
45. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe TY, Koi S, Onji M, Ohta Y, Choo QL, Houghton M, Kuo G. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6547-6549.
46. Selby MJ, Choo QL, Berger K, Kuo G, Glazer E, Eckart M, Lee C, Chien D, Kuo C, Houghton M. 1993. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol 74:1103-1113.
47. Sell S, Hunt JM, Knoll BJ, Dunsford HA. 1989. Cellular events during hepatocarcinogenesis in rats and the question of premalignancy. Adv Cancer Res 48:37-111.
48. Shirakata Y, Kawada M, Fujiki Y, Sano H, Oda M, Yaginuma K, Kobayashi M, Koike K. 1989. The × gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn J Cancer Res 80:617-621.
49. Suzuki R, Matsuura Y, Suzuki T, Ando A, Chiba J, Harada S, Saito I, Miyamura T. 1995. Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. J Gen Virol 76:53-61.
50. Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, Onishi E, Andoh T, Yoshida I, Okayama H. 1991. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 65:1105-1113.
51. Wakita T, Taya C, Katsume A, Kato J, Yonekawa H, Kanegae Y, Saito I, Hayashi Y, Koike M, Kohara M. 1998. Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system. J Biol Chem 273:9001-9006.
52. Yamamoto H, Hatano M, Iitsuka Y, Mahyar N, Yamamoto M, Tokuhisa T. 1995. Two forms of Hox11, a T cell leukemia oncogene, are expressed in fetal spleen but not in primary lymphocytes. Mol Immunol 32:1177-1182.